BMY vs MS · P/E 17, rev $48.19B vs P/E 20, $344.27B cap
Bristol-Myers Squibb Company (BMY) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
MS does not have a complete income-statement cache yet.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the BMY and MS stock pages for the full models.
Not investment advice.